235 related articles for article (PubMed ID: 31631997)
1. Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy.
Kim H; Yoo H; Pyo H; Ahn YC; Noh JM; Ju SG; Lee W; Park B; Kim JM; Kang N; Shin SH; Chung MP; Shin S; Kim HS; Park M; Park HY
Int J Chron Obstruct Pulmon Dis; 2019; 14():2273-2281. PubMed ID: 31631997
[TBL] [Abstract][Full Text] [Related]
2. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
3. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.
Kim H; Pyo H; Noh JM; Lee W; Park B; Park HY; Yoo H
Radiat Oncol; 2019 Jan; 14(1):19. PubMed ID: 30691496
[TBL] [Abstract][Full Text] [Related]
4. Risk factor analysis of the development of severe radiation pneumonitis in patients with non-small cell lung cancer treated with curative radiotherapy, with focus on underlying pulmonary disease.
Kim H; Hwang J; Kim SM; Choi J; Yang DS
BMC Cancer; 2023 Oct; 23(1):992. PubMed ID: 37848850
[TBL] [Abstract][Full Text] [Related]
5. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
6. Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
Hata A; Sekine Y; Kota O; Koh E; Yoshino I
Int J Chron Obstruct Pulmon Dis; 2016; 11():1261-8. PubMed ID: 27354784
[TBL] [Abstract][Full Text] [Related]
7. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
[TBL] [Abstract][Full Text] [Related]
8. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
[TBL] [Abstract][Full Text] [Related]
9. The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.
Takenaka T; Furuya K; Yamazaki K; Miura N; Tsutsui K; Takeo S
Surg Today; 2018 Feb; 48(2):229-235. PubMed ID: 28821979
[TBL] [Abstract][Full Text] [Related]
10. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
11. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study.
Kumagai S; Marumo S; Yamanashi K; Tokuno J; Ueda Y; Shoji T; Nishimura T; Huang CL; Fukui M
Eur J Cardiothorac Surg; 2014 Dec; 46(6):e113-9. PubMed ID: 25345566
[TBL] [Abstract][Full Text] [Related]
13. Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.
Kanzaki H; Kataoka M; Nishikawa A; Uwatsu K; Nagasaki K; Nishijima N; Ochi T; Mochizuki T
Int J Clin Oncol; 2016 Oct; 21(5):853-861. PubMed ID: 27125214
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study.
Sampath S; Hall M; Schultheiss TE
Lung Cancer; 2015 Oct; 90(1):61-4. PubMed ID: 26231092
[TBL] [Abstract][Full Text] [Related]
15. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer.
Reddy JP; Tang C; Shih T; Kim B; Kim C; Nguyen QN; Welsh J; Benveniste M; Zhang J; Liao Z; Gomez DR
Clin Lung Cancer; 2017 Mar; 18(2):141-148. PubMed ID: 27913215
[TBL] [Abstract][Full Text] [Related]
16. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
[TBL] [Abstract][Full Text] [Related]
17. Combined pulmonary fibrosis and emphysema predicts recurrence following surgery in patients with stage I non-small cell lung cancer.
Maeda R; Funasaki A; Motono N; Sekimura A; Usuda K; Uramoto H
Med Oncol; 2018 Feb; 35(3):31. PubMed ID: 29411159
[TBL] [Abstract][Full Text] [Related]
18. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
Baumann P; Nyman J; Hoyer M; Gagliardi G; Lax I; Wennberg B; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JS; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
Radiother Oncol; 2008 Sep; 88(3):359-67. PubMed ID: 18768228
[TBL] [Abstract][Full Text] [Related]
20. Chronic obstructive pulmonary disease in stage I non-small cell lung cancer that underwent anatomic resection: the role of a recurrence promoter.
Kuo CH; Wu CY; Lee KY; Lin SM; Chung FT; Lo YL; Liu CY; Hsiung TC; Yang CT; Wu YC
COPD; 2014 Aug; 11(4):407-13. PubMed ID: 24475998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
